NIFTY 50
24,718.60 (-0.68%)
NIFTY IT
38,469.25 (0.02%)
NIFTY AUTO
23,327.40 (-0.36%)
NIFTY FINANCIAL SERVICES
26,335.60 (-0.92%)
NIFTY BANK
55,527.35 (-0.99%)
NIFTY REALTY
1,007.05 (0.06%)
NIFTY ENERGY
35,740.55 (-0.50%)
NIFTY METAL
9,258.80 (-0.96%)
NIFTY FMCG
54,527.15 (-1.05%)
NIFTY HEALTH CARE
14,328.65 (0.04%)
NIFTY PHARMA
21,985.15 (-0.23%)
NIFTY MEDIA
21,985.15 (-0.23%)
Platforms
Desktop Application
Insights
Research
Videos
Markets
Equity
Derivatives
IPO
Other Markets
Corporate Information
Pricing
Support
Login
Open an Account
Home
Platform
Insights
Research
Markets
Pricing
Support
Login
Open an Account
Trend of Stock Market
A trend is the broad upward or downward movement of a stock's price over time
Forthcoming IPO
Open Issues
Closed Issue
Top Gainers / Losers
52 Weeks High/ Low
Value / Volume Toppers
Get Quotes
Nifty Futures
Top Traded Quantity
Top Traded Value
Derivative Summary
Daily Settlement Price
List Of Underlying
Put Call Ratio
FII Statistics
Most Active Contract
All Index Futures
Top Gainers
Top Losers
Highest In OI
Lowest In OI
Increase In OI
Decrease In OI
Most Active Calls
Most Active Put
Top Gainers
Top Losers
Highest In OI
Lowest In OI
Increase In OI
Decrease In OI
Forthcoming Issues
Open Issues
Closed Issue
World Indices
ADR Prices
MF Investment
FII Investment
Get Quotes
Company Snapshot
Company Background
Board of Directors
Directors Reports
Profit & Loss
Balance Sheet
Quarterly Results
Shareholding Pattern
Key Financial Ratios
Mutual Fund Holdings
Peer Comparison
Technical Chart
Company News
Change Company Name
Cipla Ltd
Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
500087
ISIN Demat
INE059A01026
Book Value
397.42
NSE Symbol
CIPLA
Dividend Yield (%)
1.06
Market Cap (
₹
Cr.)
121,589.70
P/E
24.69
EPS
60.98
Face Value
2
Date
Headline
29-May-25
Jay Precision Pharmaceuticals acquires 26% stake in AMPIN Energy C&I Eighteen
14-May-25
Cipla to convene AGM
13-May-25
Board of Cipla recommends final dividend
17-Apr-25
Cipla allots 23,282 equity shares under ESOS
11-Apr-25
Cipla receives USFDA approval for Protein-bound Paclitaxel for Injectable Suspension
08-Apr-25
Cipla to table results
08-Feb-25
USFDA classifies cGMP inspection of Cipla's Virgonagar facility as VAI
03-Feb-25
Cipla to infuse ZAR 900 million in Cipla Medpro South Africa Proprietary Limited
07-Jan-25
Cipla to table results
15-Nov-24
Cipla allots 17,064 equity shares under ESOS
Prev
1
2
3
Next